MedTrace Logo

Study of Oncological Outcomes of D3 Lymph Node Dissection in Colon Cancer

NCT03009227 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 780

Last updated 2022-04-21

No results posted yet for this study

Summary

The purpose of this study is to determine wether D3 lymph node dissection gives superior oncological outcomes compared to standard D2 lymph node dissection in colon cancer

Conditions

  • Colonic Neoplasms Malignant

Interventions

PROCEDURE

Colonic resection with D2 lymph node dissection

Appropriate to the tumor location colonic resection is performed with D2 lymph node dissection

PROCEDURE

Colonic resection with D3 lymph node dissection

Appropriate to the tumor location colonic resection is performed with D3 lymph node dissection

Sponsors & Collaborators

  • N.N. Petrov National Medical Research Center of Oncology

    lead OTHER

Principal Investigators

  • Aleksei Karachun, Ph.D. · N.N. Petrov Research Institute of Oncology, Surgical department of abdominal oncology, St. Petersburg, Russian Federation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-03
Primary Completion
2025-01-31
Completion
2025-01-31

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03009227 on ClinicalTrials.gov